CalciMedica, Inc.·4

May 10, 6:17 PM ET

Stauderman Kenneth A. 4

4 · CalciMedica, Inc. · Filed May 10, 2023

Insider Transaction Report

Form 4
Period: 2023-05-08
Stauderman Kenneth A.
Chief Scientific Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-05-08+68,98868,988 total
    Exercise: $3.25Exp: 2033-05-07Common Stock (68,988 underlying)
Footnotes (1)
  • [F1]1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION